Neurobit

New York, United States

Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.

$100K raised

Apr 2023

Angel

Top Investors

Entrepreneurs FirstEnterprise SingaporeiHealthtechNUS

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurobit raised?

Neurobit has raised $100K in total funding. The most recent round was Angel. The last funding was announced in April 2023.

Who are Neurobit's investors?

Neurobit's investors include Entrepreneurs First, Enterprise Singapore, iHealthtech, NUS.

Where is Neurobit headquartered?

Neurobit is headquartered in New York, United States.

What does Neurobit do?

Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.

What stage is Neurobit at?

Neurobit is at the Angel stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2023.

MLA

"Neurobit — Funding & Investors." VCBacked, April 1, 2023, https://www.vcbacked.co/company/neurobit. Accessed June 4, 2026.

APA

VCBacked. (2023). Neurobit — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/neurobit

Wikipedia (cite web)

{{cite web |title=Neurobit — Funding & Investors |url=https://www.vcbacked.co/company/neurobit |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2023.